title: Serious Neurologic Events after Epidural Glucocorticoid Injection--The FDA's Risk Assessment.
authors.affiliation: From the Division of Anesthesia, Analgesia and Addiction Products (J.A.R.), and the Division of Pulmonary, Allergy, and Rheumatology Products (S.M.S.), Office of New Drugs, and the Division of Pharmacovigilance 2 (L.C.) and the Division of Epidemiology 2 (R.G.), Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD.
authors.forename: Judith A
authors.initials: JA
authors.lastname: Racoosin
authors.forename: Sally M
authors.initials: SM
authors.lastname: Seymour
authors.forename: Laurelle
authors.initials: L
authors.lastname: Cascio
authors.forename: Rajdeep
authors.initials: R
authors.lastname: Gill
mesh_terms: D000328:Adult; D000368:Aged; D017277:Drug Approval / Q000331:legislation & jurisprudence; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007238:Infarction / Q000209:etiology; D007268:Injections, Epidural / Q000009:adverse effects*; D008875:Middle Aged; D010243:Paralysis / Q000209:etiology*; D018570:Risk Assessment; D013116:Spinal Cord / Q000098:blood supply; D013118:Spinal Cord Diseases / Q000209:etiology*; D020521:Stroke / Q000209:etiology*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D005938:Glucocorticoids